Copy
  November 2015 - ISSUE 18  
 

ENFit™ Tip Syringes for Low Medication Dosing

ENFit Syringe Design for Low Doses

ENFit syringes are vital to the launch of a complete ENFit enteral feeding system.  Because ENFit syringes have tips which are female small-bore connectors, concerns have been raised regarding possible risks of delivering inaccurate doses when dosing low volumes of medication that require high accuracy (0.2mL within ± 10%).  GEDSA members have been collaborating to develop a solution which delivers a highly accurate dose with minimal impact to current practices.  Through this collaboration a design has been developed that incorporates an internal feature within the female connector that effectively allows the ENFit syringe to function similarly to male tipped syringes currently on the market today while maintaining compliance to ISO 80369-3 female connector requirements.   We are currently terming this design a low dose ENFIt syringe.

 

Initial proof of concept testing has demonstrated that the low dose ENFit syringe delivers an accurate dose while meeting the requirements of ISO 7886-1 for dead space and tolerance on graduated capacity.  The low dose ENFit syringe will be introduced into the market after successful completion of validation, verification and usability studies.

GEDSA will be present at the 2015 ASHP MidYear conference in New Orleans, Louisiana.  If you are attending, please join us Sunday December 6th at 10:00am in room 276 on Level 2. We will be presenting updates on the low dose ENFit syringe and answering any questions you may have regarding all aspects of ENFit enteral feeding systems.


 

 
 

Low Dose ENFit Tip Syringe Usability Testing

GEDSA will be conducting a usability study for the new low dose ENFit tip syringe at the ASHP MidYear Conference. The study will be focus on individual 20 minute sessions allowing clinicians to try and provide feedback on the low dose ENFit tip syringe. The study will be held throughout the day Sunday December 6th 9:00am-6:00pm and Monday December 7th 7:00am-8:20am. Pharmacists and pharmacy technicians attending the conference interested in participating please contact GEDSA to set up an appointment.


Request a usability study session
 
 
   
  Did you know?  
 

GEDSA and members have recently participated in a public forum at the Association for the Advancement of Medical Instrumentation (AAMI) headquarters.  GEDSA member representatives demonstrated a positive effective flow rate testing and consistency in current systems and the future ENFit system. While actual ENFit tip syringes and feeding tubes with ENFit males are not yet available, some patients continued to express concern on the perceived reduction in flow rates.  Further collaboration between GEDSA, the Oley Foundation, ASPEN, Feeding Tube Awareness Foundation, and the FDA is underway to further consider challenges faced today by users of blenderized diets and potential solutions.


View our FAQ for Patient/Caregiver Concerns

   
  Do you have?  
 

Stay Connected Video

Get a quick refresher on the Stay Connected initiative for safer connectors and share it with your colleagues.  This short video explains misconnections, demonstrates how the new connectors work, and provides timing information.

View the Video
 

   
  Have you met?  
 

Colleen Elliott
Director, Standards
Association for the Advancement of Medical Instrumentation (AAMI)


Colleen serves as the Secretary of ISO/TC 210 – IEC/SC 62D/JWG4, Small-bore connectors, the international joint working group that is developing the ISO 80369 series of standards. She is also the US TAG Administrator of AAMI/CN, Small-bore connectors committee, the US mirror group to the international joint working group.

 

 
 

“The creation of the ISO 80369 series of small-bore connector standards has been an extraordinary standards development effort. Clinicians, regulators and manufacturers have come together, devoting thousands of hours of technical expertise, to develop global consensus on designs and requirements to reduce tubing misconnections and increase patient safety. This project exemplifies AAMI’s mission - supporting the healthcare community in the development, implementation, management, and use of safe and effective healthcare technology.”

- Colleen Elliott, AAMI

   
  Have you told?  
 

Share this email and other Stay Connected tools with patient safety directors, managers, and risk management personnel to help them keep up to date on the ENFit connector transition

Forward this email
 

   
 

Where to find us

December 6-8

American Society of Health System Pharmacists (ASHP) Clinical Midyear Conference; New Orleans, Louisiana

January 16-19

American Society for Parenteral and Enteral Nutrition (ASPEN) Clinical Nutrition Week; Austin, Texas

 
 

The Stay Connected initiative is organized by the Global Enteral Device Supplier Association (GEDSA) in partnership with leading regulators, associations and other supporting organizations.

Visit StayConnected.org

If this email was forwarded to you and you would like to sign up to Stay Connected, click here.

© 2015 GEDSA, all rights reserved

692 N. High St. Suite 207
Columbus, OH 43215 USA

Unsubscribe | Privacy

GEDSA is a 501(c)(6) federal tax exempt Non-Profit Trade Association incorporated in the State of Ohio, USA. GEDSA’s mission is to promote initiatives surrounding safe and optimal delivery of enteral feeding and connectivity. It is GEDSA’s policy and the responsibility of every GEDSA member to comply in all respects with federal, state and international antitrust laws. Any discussion is strictly prohibited for the purpose of raising, lowering, or stabilizing prices; regulating production; allocating markets; encouraging boycotts; fostering unfair trade practices; or assisting monopolization at any GEDSA function. Any questions regarding the meaning or applicability of this policy, as well as any concerns regarding activities or discussions at GEDSA functions, should be promptly brought to the attention of GEDSA’s executive director, officers, and/or legal counsel.

All material provided in this email is intended for informational purposes only and should not be used to replace regulatory or company-specific documents, nor should it replace the advice of a qualified professional. This information is based on the draft ISO 80369 standard; does not imply or suggest any regulatory clearance of any specific product and may not be predictive of clinical outcomes. Images provided do not imply endorsement of any specific product. All products and product designs are the responsibility of each specific legal manufacturer, distributor or supplier. Products with these design features may be pending regulatory clearance or may not be available in a specific geography. Consult your supplier representative for product-specific availability, indications, contraindications, precautions, and warnings.

 

This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
GEDSA · 692 N. High St. Suite 304 · Columbus, OH 43215 · USA